Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMNN similar filings
- 27 Feb 25 IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer
- 10 Feb 25 IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer
- 27 Nov 24 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 7 Nov 24 IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates
- 7 Oct 24 Departure of Directors or Certain Officers
Filing view
External links